SYS-MEL
SYS-MEL is a 7-partner Marie Curie Action: Industry-Academia Partnerships and Pathways project (FP7-PEOPLE-2013) funded under “FP7-PEOPLE" coordinated by University College Dublin in Ireland.
The aim of SYS-MEL is to identify and validate prognostic and predictive biomarkers for melanoma, and to model the predictive value of these biomarkers in determining the efficacy of melanoma therapies. Read more here.
